| Primary |
| Colorectal Cancer Metastatic |
18.9% |
| Breast Cancer |
14.1% |
| Colon Cancer |
12.1% |
| Colorectal Cancer |
11.6% |
| Oesophageal Carcinoma |
6.9% |
| Rectal Cancer |
5.2% |
| Gastric Cancer |
5.1% |
| Colon Cancer Metastatic |
3.5% |
| Head And Neck Cancer |
2.8% |
| Metastatic Gastric Cancer |
2.6% |
| Product Used For Unknown Indication |
2.3% |
| Nausea |
2.0% |
| Breast Cancer Metastatic |
1.8% |
| Nasopharyngeal Cancer |
1.8% |
| Colon Cancer Stage Iii |
1.7% |
| Neoplasm Malignant |
1.6% |
| Prophylaxis |
1.6% |
| Metastases To Liver |
1.5% |
| Oesophageal Squamous Cell Carcinoma |
1.5% |
| Neoplasm |
1.5% |
|
| Vomiting |
14.9% |
| Neutropenia |
9.5% |
| Pulmonary Embolism |
7.7% |
| Febrile Neutropenia |
6.7% |
| Thrombocytopenia |
6.5% |
| Diarrhoea |
6.4% |
| Pyrexia |
5.7% |
| Interstitial Lung Disease |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Nausea |
4.1% |
| Toxicity To Various Agents |
3.7% |
| Sepsis |
3.6% |
| Pneumonia |
3.2% |
| Urinary Tract Infection |
3.2% |
| Stomatitis |
3.1% |
| Leukopenia |
2.8% |
| Weight Decreased |
2.8% |
| Mucosal Inflammation |
2.7% |
| Respiratory Failure |
2.5% |
| Neutrophil Count Decreased |
2.4% |
|
| Secondary |
| Colon Cancer |
15.6% |
| Colorectal Cancer |
15.0% |
| Colorectal Cancer Metastatic |
13.5% |
| Breast Cancer |
9.7% |
| Drug Use For Unknown Indication |
8.4% |
| Rectal Cancer |
6.0% |
| Colon Cancer Metastatic |
4.5% |
| Head And Neck Cancer |
4.1% |
| Gastric Cancer |
3.1% |
| Prophylaxis |
3.0% |
| Hypertension |
2.6% |
| Premedication |
2.4% |
| Product Used For Unknown Indication |
2.1% |
| Nausea |
1.7% |
| Pain |
1.6% |
| Large Intestine Carcinoma |
1.5% |
| Rectal Cancer Metastatic |
1.4% |
| Oesophageal Carcinoma |
1.4% |
| Squamous Cell Carcinoma |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
|
| Vomiting |
15.7% |
| Pyrexia |
8.0% |
| Thrombocytopenia |
7.5% |
| White Blood Cell Count Decreased |
6.2% |
| Stomatitis |
5.8% |
| Sepsis |
5.7% |
| Neutropenia |
5.5% |
| Interstitial Lung Disease |
5.2% |
| Death |
5.1% |
| Pulmonary Embolism |
4.4% |
| Febrile Neutropenia |
3.7% |
| Disease Progression |
3.6% |
| Diarrhoea |
3.3% |
| Renal Failure Acute |
3.2% |
| Mucosal Inflammation |
3.0% |
| Respiratory Failure |
3.0% |
| Pneumonia |
2.8% |
| General Physical Health Deterioration |
2.8% |
| Neutrophil Count Decreased |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
|
| Concomitant |
| Colorectal Cancer |
21.3% |
| Colon Cancer |
13.7% |
| Drug Use For Unknown Indication |
11.9% |
| Breast Cancer |
7.5% |
| Colon Cancer Metastatic |
6.9% |
| Colorectal Cancer Metastatic |
5.8% |
| Prophylaxis |
4.9% |
| Rectal Cancer |
4.5% |
| Premedication |
3.4% |
| Large Intestine Carcinoma |
3.2% |
| Chemotherapy |
3.0% |
| Rectal Cancer Metastatic |
2.2% |
| Metastases To Bone |
1.9% |
| Product Used For Unknown Indication |
1.8% |
| Hypertension |
1.5% |
| Colon Cancer Recurrent |
1.5% |
| Breast Cancer Metastatic |
1.5% |
| Prophylaxis Of Nausea And Vomiting |
1.4% |
| Rectal Cancer Recurrent |
1.1% |
| Pain |
1.0% |
|
| Interstitial Lung Disease |
10.4% |
| Vomiting |
9.5% |
| White Blood Cell Count Decreased |
6.8% |
| Death |
5.9% |
| Disease Progression |
5.7% |
| Pyrexia |
5.6% |
| Pulmonary Embolism |
5.1% |
| Rash |
5.1% |
| Sepsis |
4.9% |
| Stomatitis |
4.7% |
| Neutropenia |
4.4% |
| Diarrhoea |
4.2% |
| Thrombocytopenia |
4.1% |
| Neuropathy Peripheral |
3.9% |
| Dermatitis Acneiform |
3.8% |
| Anaphylactic Shock |
3.5% |
| Weight Decreased |
3.4% |
| Febrile Neutropenia |
3.3% |
| Colorectal Cancer |
2.9% |
| Disseminated Intravascular Coagulation |
2.9% |
|
| Interacting |
| Breast Cancer |
39.8% |
| Metastasis |
8.4% |
| Colorectal Cancer |
7.6% |
| Rectal Cancer |
6.4% |
| Colon Cancer |
5.6% |
| Colon Cancer Metastatic |
5.6% |
| Drug Use For Unknown Indication |
4.0% |
| Colon Cancer Stage Iv |
3.2% |
| Adenocarcinoma Of Colon |
2.4% |
| Colorectal Cancer Metastatic |
2.4% |
| Herpes Zoster |
2.0% |
| Osteoporosis |
2.0% |
| Antibiotic Therapy |
1.6% |
| Breast Cancer Metastatic |
1.6% |
| Oral Disorder |
1.6% |
| Premedication |
1.6% |
| Actinic Keratosis |
1.2% |
| Colony Stimulating Factor Prophylaxis |
1.2% |
| Colony Stimulating Factor Therapy |
0.8% |
| Herpes Virus Infection |
0.8% |
|
| Drug Interaction |
15.7% |
| Osteonecrosis |
13.7% |
| Pyrexia |
11.8% |
| Weight Decreased |
11.8% |
| Lower Limb Fracture |
5.9% |
| Neutropenia |
5.9% |
| Malaise |
3.9% |
| Myocardial Infarction |
3.9% |
| Skin Toxicity |
3.9% |
| Thrombocytopenia |
3.9% |
| Dizziness |
2.0% |
| Extrasystoles |
2.0% |
| Interstitial Lung Disease |
2.0% |
| Jaundice |
2.0% |
| Lethargy |
2.0% |
| Musculoskeletal Pain |
2.0% |
| Pleural Effusion |
2.0% |
| Presyncope |
2.0% |
| Pruritus |
2.0% |
| Somnolence |
2.0% |
|
